Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-31 4:56 pm Sale | 2025-06-30 | 13G | Translational Development Acquisition Corp. TDAC | BANK OF MONTREAL BMO | 800,000 4.640% | -200,000 (-20.00%) | Filing History |
| 2025-07-11 12:06 pm Purchase | 2025-06-30 | 13G | Translational Development Acquisition Corp. TDAC | WOLVERINE ASSET MANAGEMENT LLC | 1,354,691 7.850% | 277,606 (+25.77%) | Filing History |
| 2025-05-14 4:15 pm Sale | 2025-03-31 | 13G | Translational Development Acquisition Corp. TDAC | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 400,000 2.300% | -500,000 (-55.56%) | Filing History |
| 2025-05-14 12:33 pm Sale | 2025-03-31 | 13G | Translational Development Acquisition Corp. TDAC | AQR CAPITAL MANAGEMENT LLC | 1,099,989 6.380% | -385,011 (-25.93%) | Filing History |
| 2025-05-08 1:14 pm Purchase | 2025-03-31 | 13G | Translational Development Acquisition Corp. TDAC | BANK OF MONTREAL BMO | 1,000,000 5.790% | 1,000,000 (New Position) | Filing History |
| 2025-05-01 3:33 pm Purchase | 2025-03-31 | 13G | Translational Development Acquisition Corp. TDAC | WOLVERINE ASSET MANAGEMENT LLC | 1,077,085 6.240% | 1,077,085 (New Position) | Filing History |
| 2025-02-14 4:01 pm Purchase | 2024-12-31 | 13G | Translational Development Acquisition Corp. TDAC | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 900,000 5.200% | 900,000 (New Position) | Filing History |
| 2025-02-14 11:56 am Purchase | 2024-12-31 | 13G | Translational Development Acquisition Corp. TDAC | AQR CAPITAL MANAGEMENT LLC | 1,485,000 8.610% | 1,485,000 (New Position) | Filing History |
| 2025-01-29 10:07 am Purchase | 2024-12-31 | 13G | Translational Development Acquisition Corp. TDACU | Magnetar Financial LLC | 1,300,000 7.530% | 1,300,000 (New Position) | Filing History |